BEVERLY HILLS, Calif. (AP) _ Capricor Therapeutics Inc. (CAPR) on Thursday reported a loss of $3.9 million in its third quarter.
On a per-share basis, the Beverly Hills, California-based company said it had a loss of 20 cents.
The biotechnology company posted revenue of $16,900 in the period. Its adjusted revenue was $17,000.
In the final minutes of trading on Thursday, the company’s shares hit $4.65. A year ago, they were trading at $1.92.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CAPR at https://www.zacks.com/ap/CAPR
The Associated Press
